StockNews.AI
EBS
StockNews.AI
8 hrs

Emergent BioSolutions to Participate in Upcoming Investor Conferences

1. EBS to participate in Wells Fargo Healthcare Conference on September 4. 2. One-on-one meetings available with senior management during conferences. 3. HCW Annual Global Investment Conference scheduled for September 9. 4. Investors can view presentations on the company's website.

12m saved
Insight
Article

FAQ

Why Neutral?

Participation in investor conferences usually has a neutral to slightly positive impact, depending on the content shared. Historical examples show that proactive investor engagements may stabilize or incrementally boost stock prices.

How important is it?

Investor conferences can enhance visibility and market confidence, impacting stock performance. However, the direct implications on price remain uncertain without substantial company announcements.

Why Short Term?

The upcoming conferences can affect EBS stock in the short term as investors react to any new information disclosed. Quick reactions to conference outcomes can be seen within days.

Related Companies

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that members of the company's senior management team will participate in the following investor conferences:

  • Wells Fargo 20th Annual Healthcare Conference

    September 4, 2025

    3:00 pm ET

    Webcast link here

    One-on-one meetings
  • HCW 27th Annual Global Investment Conference

    September 9, 2025

    1:30 PM ET

    Webcast link here

    One-on-one meetings

Please contact your conference representative to request one-on-one meetings.

Participants can view the presentations and replays by visiting the Investors page of Emergent's website.

About Emergent BioSolutions

At Emergent, our mission is to protect and save lives. For over 25 years, we've been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today's health challenges and tomorrow's threat, visit our website and follow us on LinkedInXInstagramApple Podcasts and Spotify.

Investor Contact:

Richard S. Lindahl

Executive Vice President, CFO

lindahlr@ebsi.com  

Media Contact:

Assal Hellmer

Vice President, Communications

mediarelations@ebsi.com



Primary Logo

Related News